We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UCB:EURONEXT BRUSSELSUCB S.A. Analysis

Data as of 2026-06-03 - not real-time

$32.88

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

United Community Banks (UCB) is trading at $32.88, comfortably above its 20‑day SMA (≈$33.0) and 50‑day SMA (≈$32.9) while still below the 200‑day SMA ($32.22), indicating a short‑term bullish tilt within a longer‑term uptrend. Technical indicators show a neutral RSI at 49, a bearish MACD histogram, but an increasing volume trend and a clear support level at $31.84 versus resistance at $34.26, suggesting limited downside risk in the near term. Fundamentally, the stock trades at a forward PE of 9.9 versus an industry average of 16.6, and a price‑to‑book of 1.09, positioning it as a relative value play. The DCF fair‑value estimate of $53.67 implies a material upside potential, while the current dividend yield of 3.04% with a 36% payout ratio signals attractive income.
Recent material news adds a strategic catalyst: the announced merger with Peach State Bancshares is expected to broaden UCB’s geographic footprint and loan portfolio, while Q1 2026 net income of $84.3 million and 14.4% revenue growth underscore a robust earnings trajectory. Combined with a solid cash position ($623 M) and low leverage, the company appears well‑positioned to sustain its dividend and capture the upside suggested by valuation models.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Technical support at $31.84 and rising volume
  • Bearish MACD but overall bullish trend
  • Pending merger integration risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Accretive acquisition of Peach State
  • Strong earnings growth and low PE relative to peers
  • Sustainable dividend yield

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term valuation gap to DCF fair value
  • Stable cash generation and low leverage
  • Continued dividend growth potential

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin32.54%
P/E Ratio12.0
ROE9.53%
ROA1.22%
P/B Ratio1.1
Op. Cash Flow$354.7M
Industry P/E16.6

Technical Analysis

TrendBullish
RSI49.0
Support$31.84
Resistance$34.26
MA 20$32.99
MA 50$32.90
MA 200$32.22
MACDBearish
VolumeIncreasing
Fear & Greed Index92.79

Valuation

Fair Value$53.67
Target Price$38.17
Upside/Downside16.08%
GradeUndervalued
TypeBlend
Dividend Yield3.04%

Risk Assessment

Beta0.94
Volatility23.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.